Advertisement
Advertisement
AMRN
Amarin Corp Plc
14.67
USDSponsored
-0.13
-0.85%
Mar 26, 15:59 UTC -4
Closed
Pre-Market
15.05
+0.38
+2.62%
AMRN Earnings Reports
Positive Surprise Ratio
AMRN beat 27 of 41 last estimates.
66%
Next Report
Date of Next Report
May 05, 2026
Estimate for Q1 26 (Revenue/ EPS)
$44.65M
/$0.08
Implied change from Q4 25 (Revenue/ EPS)
-9.29%
/+700.00%
Implied change from Q1 25 (Revenue/ EPS)
+6.26%
/-110.53%
Amarin Corp Plc earnings per share and revenue
On Feb 25, 2026, AMRN reported earnings of 0.01 USD per share (EPS) for Q4 25, Inline the estimate of 0.00 USD, resulting in a 0.00% surprise. Revenue reached 49.22 million, compared to an expected 51.63 million, with a -4.67% difference. The market reacted with a -9.47% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 3 analysts forecast an EPS of 0.08 USD, with revenue projected to reach 44.65 million USD, implying an increase of 700.00% EPS, and decrease of -9.29% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Candel Therapeutics, Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.25
Actual
-$0.54
Surprise
-115.31%
Acumen Pharmaceuticals, Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.46
Actual
-$0.41
Surprise
+11.29%
Rani Therapeutics Holdings, Inc. Class A Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.06
Actual
-$0.07
Surprise
-2.94%
Spero Therapeutics, Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.20
Actual
$0.53
Surprise
+359.80%
Alpha Cognition Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.27
Actual
-$0.30
Surprise
-8.93%
Cognition Therapeutics, Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.02
Surprise
+76.47%
Celcuity Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$1.06
Actual
-$0.97
Surprise
+8.72%
Dyadic International, Inc.
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.04
Actual
-$0.06
Surprise
-30.72%
Quantum Biopharma Ltd. Class B Subordinate Voting Shares
Report Date
Mar 26, 2026 For Q4 25
Estimate
-Actual
-$0.71
Surprise
-
CollPlant Biotechnologies Ltd Ordinary Shares
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.67
Surprise
-245.72%
FAQ
What were Amarin Corp Plc's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Amarin Corp Plc reported EPS of $0.01, missing estimates by 0%, and revenue of $49.22M, -4.67% below expectations.
How did the market react to Amarin Corp Plc's Q4 2025 earnings?
The stock price moved down -9.47%, changed from $15.52 before the earnings release to $14.05 the day after.
When is Amarin Corp Plc expected to report next?
The next earning report is scheduled for May 05, 2026.
What are the forecasts for Amarin Corp Plc's next earnings report?
Based on 3
analysts, Amarin Corp Plc is expected to report EPS of $0.08 and revenue of $44.65M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement